Unknown

Dataset Information

0

Structural insights and molecular dynamics into the inhibitory mechanism of a Kunitz-type trypsin inhibitor from Tamarindus indica L.


ABSTRACT: Trypsin inhibitors from tamarind seed have been studied in vitro and in preclinical studies for the treatment of obesity, its complications and associated comorbidities. It is still necessary to fully understand the structure and behaviour of these molecules. We purifed this inhibitor, sequenced de novo by MALDI-TOF/TOF, performed its homology modelling, and assessed the interaction with the trypsin enzyme through molecular dynamics (MD) simulation under physiological conditions. We identified additional 75 amino acid residues, reaching approximately 72% of total coverage. The four best conformations of the best homology modelling were submitted to the MD. The conformation n°287 was selected considering the RMSD analysis and interaction energy (-301.0128 kcal.mol-1). Residues Ile (54), Pro (57), Arg (59), Arg (63), and Glu (78) of pTTI presented the highest interactions with trypsin, and arginine residues were mainly involved in its binding mechanism. The results favour bioprospecting of this protein for pharmaceutical health applications.

SUBMITTER: de Medeiros AF 

PROVIDER: S-EPMC7875565 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural insights and molecular dynamics into the inhibitory mechanism of a Kunitz-type trypsin inhibitor from <i>Tamarindus indica</i> L.

de Medeiros Amanda Fernandes AF   de Souza Beatriz Blenda Pinheiro BBP   Coutinho Lucas Pinheiro LP   Murad Aline Melro AM   Dos Santos Paula Ivani Medeiros PIM   Monteiro Norberto de Kássio Vieira NKV   Santos Elizeu Antunes Dos EAD   Santos Elizeu Antunes Dos EAD   Maciel Bruna Leal Lima BLL   de Araújo Morais Ana Heloneida AH  

Journal of enzyme inhibition and medicinal chemistry 20211201 1


Trypsin inhibitors from tamarind seed have been studied <i>in vitro</i> and in preclinical studies for the treatment of obesity, its complications and associated comorbidities. It is still necessary to fully understand the structure and behaviour of these molecules. We purifed this inhibitor, sequenced <i>de novo</i> by MALDI-TOF/TOF, performed its homology modelling, and assessed the interaction with the trypsin enzyme through molecular dynamics (MD) simulation under physiological conditions. W  ...[more]

Similar Datasets

| S-EPMC7320042 | biostudies-literature
| PRJNA579714 | ENA
| S-EPMC4493575 | biostudies-literature
| S-EPMC3210814 | biostudies-literature
| S-EPMC8758671 | biostudies-literature
| S-EPMC2777053 | biostudies-literature
| S-EPMC3861661 | biostudies-literature
| S-EPMC11369452 | biostudies-literature
| S-EPMC6048452 | biostudies-literature
| S-EPMC9372063 | biostudies-literature